- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Health Services (Cross-Border Health Care and Miscellaneous Amendments) (Northern Ireland) (EU Exit) Regulations 2019.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Regulation 16
Textual Amendments
F1Words in Sch. 1 heading substituted (31.12.2020 immediately before IP completion day) by The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 15(a)
1. The modifications of the 2013 Regulations referred to in regulation 16 are that those Regulations are to be read as if—N.I.
(a)in regulation 2 (interpretation)—
(i)in the definition of “resident patient”, for “the United Kingdom is” there were substituted “ immediately before [F2IP completion day] the United Kingdom was ”;
(ii)in the definition of “visiting patient”, for “a member State other than the United Kingdom is” there were substituted “ immediately before [F2IP completion day] a member State other than the United Kingdom was ”;
(b)in the heading to regulation 5 (national contact point: information about treatment in another member State), for “another member State” there were substituted “ a member State ”;
(c)in regulation 5—
(i)for references to “other member States” there were substituted “ member States ”;
(ii)for the reference to “another member State” there were substituted “ a member State ”;
(d)regulation 5A (National Contact Point: information about prescriptions intended to be used in another member State) were omitted;
F3(e). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(f)regulation 7 (National Contact Point: duty to consult) were omitted;
(g)in regulation 12—
(i)in paragraph (2) for “P is” there were substituted “ immediately before [F2IP completion day] P was ”;
(ii)in paragraph (2)(a), for “is resident” there were substituted “ was resident ”;
(iii)in paragraph (2)(b), for “is the competent member State” there were substituted “ was the competent member State ”;
(iv)in paragraph (4)(b) at the end there were inserted “as it had effect immediately before [F2IP completion day]”;
(h)the schedule (elements that must be included in prescriptions intended to be used in another member State) were omitted.
Textual Amendments
F2Words in Sch. 1 substituted (31.12.2020 immediately before IP completion day) by The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 15(a)
F3Sch. 1 para. 1(e) omitted (31.12.2020 immediately before IP completion day) by virtue of The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 15(b)
Commencement Information
I1Sch. 1 para. 1 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)
Regulation 17
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F4Sch. 2 omitted (31.12.2020 immediately before IP completion day) by virtue of The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 16
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: